Key findings
- Chart review, 2019: of 893 adult admissions, 149 had a laboratory diagnosis of malaria and 22 of the 149 (14.8%) died.
- Chart review, 2019: mortality was 30% (6 of 20) in severe malaria and 12.4% (16 of 129) in non-severe malaria.
- Prospective cohort, 2022 to 2023 (preprint, not peer reviewed): of 184 adults enrolled, 34 (18.5%) died in hospital or within 30 days of discharge.
- Prospective cohort (preprint, not peer reviewed): verbal autopsy was completed for 23 of the 34 deaths and assigned malaria as the underlying cause in 3 (13.0%).
About this study
Background
Round one of HEAL-SL identified malaria as the leading cause of death in children and adults. The high malaria mortality in adults challenges current understanding and needs further investigation. This study follows adults aged 18 to 69 admitted to Bo Government Hospital with acute febrile illness, through discharge or death.
Design
The study has four objectives: to determine the causes of death, the accuracy of verbal autopsy in classifying them, and the usefulness of baseline and serial biomarkers for predicting who will die and for classifying the cause of death. Causes of death are assessed by verbal autopsy and by minimally invasive tissue sampling (MITS).
What was done
A retrospective chart review covered adults admitted from 1 January to 31 December 2019.
HEAL-SL staff then recruited a prospective cohort of 184 adults admitted with fever between 29 September 2022 and 20 September 2023 and followed them to 30 days after discharge. HEAL-SL staff conducted verbal autopsies for those who died.
Patients who died in hospital or within 30 days of discharge were included in the adult MITS study of the Child Health and Mortality Prevention Surveillance (CHAMPS) network, which performed the tissue sampling. The primary objective of that study is to assess the role of malaria as a contributor to death in adults. CHAMPS completed MITS for about 200 adults in Bo by June 2024.
Results
In the chart review, 149 of 893 adult admissions had laboratory-diagnosed malaria and 22 (14.8%) died. Mortality was 30% (6 of 20) in severe and 12.4% (16 of 129) in non-severe malaria.
In the cohort (a preprint that has not passed peer review), 34 of 184 (18.5%) died. Verbal autopsy was completed for 23 deaths and assigned malaria as the underlying cause in 3 (13.0%).
Status
Fieldwork is complete. CHAMPS leads the analysis of the MITS cases, including the comparison of MITS findings with verbal autopsy. MITS and biomarker results are not yet reported.
Outputs
Adult malaria mortality during 2019 at Bo Government Hospital, Sierra Leone
PublishedJournal article · March 2023Kpagoi SSTK, et al. Gates Open Research 2023;7:48. Version 2 published 14 August 2023; peer review: 2 approved.
Diagnosis, Treatment, and Outcomes of Adults Admitted with Possible Malaria at a District Hospital in Sierra Leone: A Prospective Observational Study
PublishedPreprint · December 2024Gelband H, et al. VeriXiv, 2024. Preprint; has not passed peer review.
Study team
- Partners
- Njala University
- Bo Government Hospital
- Centre for Global Health Research, University of Toronto
- McMaster University
- Child Health and Mortality Prevention Surveillance (CHAMPS)
- Bill & Melinda Gates Foundation (funder)
- Canadian Institutes of Health Research (funder)
- Study leads
- Prof. Rashid Ansumana — Njala University
- Prof. Prabhat Jha — University of Oxford